1. Home
  2. FUSE vs CTSO Comparison

FUSE vs CTSO Comparison

Compare FUSE & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fusemachines Inc.

FUSE

Fusemachines Inc.

HOLD

Current Price

$0.82

Market Cap

28.6M

Sector

Technology

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.38

Market Cap

23.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUSE
CTSO
Founded
2013
1997
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
23.9M
IPO Year
2025
2008

Fundamental Metrics

Financial Performance
Metric
FUSE
CTSO
Price
$0.82
$0.38
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
3.4M
57.1K
Earning Date
06-05-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
96.38
65.79
EPS
N/A
N/A
Revenue
$7,714,000.00
$22,503,908.00
Revenue This Year
N/A
$10.34
Revenue Next Year
N/A
$22.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.53
52 Week Low
$0.75
$0.35
52 Week High
$3.67
$1.04

Technical Indicators

Market Signals
Indicator
FUSE
CTSO
Relative Strength Index (RSI) 43.60 49.87
Support Level $0.81 $0.36
Resistance Level $1.93 $0.40
Average True Range (ATR) 0.17 0.03
MACD 0.00 0.00
Stochastic Oscillator 5.93 59.60

Price Performance

Historical Comparison
FUSE
CTSO

About FUSE Fusemachines Inc.

Fusemachines Inc is a provider of enterprise AI solutions, offering products such as AI Studio, AI Engines, and AI Agents, along with supporting services across various industries. Its solutions are supported by a talent pool from underserved communities, enabling scalable and high-quality AI delivery while promoting access to AI. The Company serves clients across industries, including healthcare, media, technology, and government, helping address challenges such as improving forecasting accuracy, reducing data entry errors, automating recruitment, and detecting fraud. Its product suite includes AI Studio, AI Engines, and AI Agents, designed to build, deploy, and scale AI solutions, and it operates in Nepal and the United States.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: